11012554

Source:http://linkedlifedata.com/resource/pubmed/id/11012554

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013089, umls-concept:C0015133, umls-concept:C0020823, umls-concept:C0031327, umls-concept:C0032659, umls-concept:C0149925, umls-concept:C1274040, umls-concept:C1516213, umls-concept:C2603343
pubmed:issue	4
pubmed:dateCreated	2000-11-13
pubmed:abstractText	To determine the population pharmacokinetic (PK) parameters of doxorubicin (Dox), etoposide (Eto) and ifosfamide (Ifo) in small cell lung cancer (SCLC) patients, to assess the potential relationship between those parameters and to estimate the impact of individual morphological and biological covariates on patients' PK parameters.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-2016631, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-2803920, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-2824707, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-2910494, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-2930694, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-3042244, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-6520164, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-6707876, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-7752255, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-8069602, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-8070218, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-8137456, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-8269587, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-8622075, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-8864315, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-9251720, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-9443625, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-9667242, http://linkedlifedata.com/resource/pubmed/commentcorrection/11012554-9667243
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7503323
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0306-5251
pubmed:author	pubmed-author:ArdietCC, pubmed-author:BoisselJ PJP, pubmed-author:Court-FortuneII, pubmed-author:FreyerGG, pubmed-author:GirardPP, pubmed-author:LigneauBB, pubmed-author:RebattuPP, pubmed-author:RiouRR, pubmed-author:SouquetP JPJ, pubmed-author:TranchandBB, pubmed-author:Trillet-LenoirVV
pubmed:issnType	Print
pubmed:volume	50
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	315-24
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:11012554-Aged, pubmed-meshheading:11012554-Antineoplastic Agents, pubmed-meshheading:11012554-Carcinoma, Small Cell, pubmed-meshheading:11012554-Doxorubicin, pubmed-meshheading:11012554-Etoposide, pubmed-meshheading:11012554-Humans, pubmed-meshheading:11012554-Ifosfamide, pubmed-meshheading:11012554-Lung Neoplasms, pubmed-meshheading:11012554-Middle Aged
pubmed:year	2000
pubmed:articleTitle	Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
pubmed:affiliation	Medical Oncology Unit and EA 643, Centre Hospitalier Lyon-Sud, Pierre-Bénite, Pharmacology Unit, Centre Léon Bérard, Lyon, France. Gilles.Freyer@chu-lyon.fr
pubmed:publicationType	Journal Article, Clinical Trial, Controlled Clinical Trial, Multicenter Study